JP2008501316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008501316A5 JP2008501316A5 JP2007509640A JP2007509640A JP2008501316A5 JP 2008501316 A5 JP2008501316 A5 JP 2008501316A5 JP 2007509640 A JP2007509640 A JP 2007509640A JP 2007509640 A JP2007509640 A JP 2007509640A JP 2008501316 A5 JP2008501316 A5 JP 2008501316A5
- Authority
- JP
- Japan
- Prior art keywords
- lactobacillus
- composition
- isolated
- cytoprotective compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56404904P | 2004-04-20 | 2004-04-20 | |
| PCT/US2005/013646 WO2005112976A2 (en) | 2004-04-20 | 2005-04-20 | Probiotic compounds from lactobacillus gg and uses therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008501316A JP2008501316A (ja) | 2008-01-24 |
| JP2008501316A5 true JP2008501316A5 (cg-RX-API-DMAC7.html) | 2009-01-22 |
Family
ID=35428847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007509640A Abandoned JP2008501316A (ja) | 2004-04-20 | 2005-04-20 | ラクトバシルスｇｇ由来プロバイオティック化合物及びそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070123460A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1745142A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008501316A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1997748A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2563702A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005112976A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| EP1744767A4 (en) * | 2004-04-20 | 2008-08-13 | Univ Chicago | THERAPEUTIC DELIVERY SYSTEM WITH PEG-LIKE CONNECTION WITH HIGH MOLECULAR WEIGHT |
| CA2607949C (en) | 2005-05-31 | 2012-09-25 | Thomas William-Maxwell Boileau | Feline probiotic bifidobacteria |
| AR052472A1 (es) | 2005-05-31 | 2007-03-21 | Iams Company | Lactobacilos probioticos para felinos |
| AU2008211600B8 (en) | 2007-02-01 | 2014-02-13 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts |
| CN101273737B (zh) * | 2007-03-28 | 2011-08-24 | 哈尔滨正方科技有限公司 | 一种在常温下保持高活菌数的发酵乳饮料的制备方法 |
| US9771199B2 (en) * | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| ES2568938T3 (es) | 2009-04-28 | 2016-05-05 | Vanderbilt University | Composiciones y procedimientos de tratamiento de trastornos que implican apoptosis de células epiteliales |
| US9848760B2 (en) * | 2009-06-29 | 2017-12-26 | Gearbox, Llc | Devices for continual monitoring and introduction of gastrointestinal microbes |
| WO2011009848A2 (en) * | 2009-07-20 | 2011-01-27 | Bracco Spa | Therapeutic use of probiotics |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| EP2295535A1 (en) * | 2009-09-11 | 2011-03-16 | Mead Johnson Nutrition Company | Probiotic material |
| US9730969B2 (en) | 2015-11-06 | 2017-08-15 | Mead Johnson Nutrition Company | Nutritional compositions for promoting gut barrier function and ameliorating visceral pain |
| US20180161381A1 (en) * | 2016-12-12 | 2018-06-14 | Mead Johnson Nutrition Company | Nutritional compositions and methods for reducing the occurrence or severity of viral infections, bacterial infections and viral and bacterial co-infections |
| CN113925884B (zh) * | 2020-06-29 | 2024-05-14 | 创百股份有限公司 | 后生元提取物用于促进皮肤再生与抗老化的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413785A (en) * | 1993-01-27 | 1995-05-09 | New England Deaconess Hospital Corp. | Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo |
| EP1283888B1 (en) * | 2000-05-25 | 2008-06-04 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri |
| US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
-
2005
- 2005-04-20 JP JP2007509640A patent/JP2008501316A/ja not_active Abandoned
- 2005-04-20 EP EP05779952A patent/EP1745142A4/en not_active Withdrawn
- 2005-04-20 WO PCT/US2005/013646 patent/WO2005112976A2/en not_active Ceased
- 2005-04-20 CN CNA2005800195831A patent/CN1997748A/zh active Pending
- 2005-04-20 CA CA002563702A patent/CA2563702A1/en not_active Abandoned
-
2006
- 2006-10-16 US US11/581,719 patent/US20070123460A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008501316A5 (cg-RX-API-DMAC7.html) | ||
| CN113736695B (zh) | 用于改善肠屏障功能的益生菌菌株及其应用 | |
| ES2569391T3 (es) | Tritocualina para uso en el tratamiento de la fibrosis quística | |
| JP2010526840A5 (cg-RX-API-DMAC7.html) | ||
| KR101302315B1 (ko) | 피라졸 유도체를 포함하는 호흡기 질환 예방 및 치료용 조성물 | |
| CN104144693A (zh) | 用于治疗肝脏疾病和障碍的组合物和方法 | |
| JP2008538288A5 (cg-RX-API-DMAC7.html) | ||
| KR20190084056A (ko) | 인간 지방간염(nafld/nash)의 치료 및 역행을 위한 서방성 피르페니돈 함유 조성물의 약학적 용도 | |
| US20230218592A1 (en) | Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizer | |
| KR20240054338A (ko) | 시아노 화합물, 이의 제조 방법 및 용도 | |
| WO2014053592A1 (en) | Esters of short chains fatty acids for use in the treatment of immunogenic disorders | |
| CN112888448B (zh) | 单形巨单胞菌在预防和/或治疗代谢性疾病中的用途 | |
| CN118497080A (zh) | 一种发酵粘液乳杆菌及其在制备缓解溃疡性结肠炎产品中的应用 | |
| CN114796221A (zh) | 汉防己甲素联合全反式维甲酸在制备治疗尘肺病的药物中的应用 | |
| CN113546089B (zh) | 1-乙基-3，7-二甲基黄嘌呤在制备治疗肺炎药物中的应用 | |
| KR20220116468A (ko) | 펩티드 및 다당류의 새로운 접합체 | |
| WO2017155053A1 (ja) | 非アルコール性脂肪性肝疾患／非アルコール性脂肪性肝炎の治療剤 | |
| CN108578420B (zh) | 木犀草苷在制备防治脓毒血症药物中的应用 | |
| CN113101283B (zh) | 一种多苯环共轭分子在制备抗病毒药物中的用途及抗病毒药物 | |
| CN111700918B (zh) | 一种用于缓解酒精性肠道损伤的药品 | |
| AU2011208939B2 (en) | Compounds for use in the treatment of diseases | |
| JP4232866B2 (ja) | 細胞障害抑制剤 | |
| CN108641980B (zh) | 一种缓解内毒素感染的卵形拟杆菌及其应用 | |
| CN111635874A (zh) | 一株能够调控肠道阿克曼菌属相对丰度的脆弱拟杆菌 | |
| JP2010523506A5 (cg-RX-API-DMAC7.html) |